David A. Anthoney
St James University Hospital, Beckett Street
Leeds, ENG, United Kingdom
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 01, 2024
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2019
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma.
Journal: British journal of cancer
Published: July 11, 2017
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.
Journal: The Lancet. Oncology
Published: April 13, 2015
Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients.
Journal: Science translational medicine
Published: June 16, 2012
Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses.
Journal: BMC cancer
Published: February 29, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026